Dominick Angiolillo, MD, PhD, on the TWILIGHT Trial Analysis of High-Risk Patients With Diabetes
In this podcast, Dominick J. Angiolillo, MD, PhD, provides insight into a new analysis of the TWILIGHT trial that he and his colleagues performed among high-risk patients with diabetes. It was a topic he discussed during ACC.20/WCC Virtual, when he presented the session, \u201cTicagrelor With and Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: Insights From the TWILIGHT Trial.\u201d For more, click here: www.consultant360.com/cardiology